Health
EC nod for Biocon co-developed cancer cure drug
Bengaluru, Dec 19: The European Commission (EC) has approved the cancer cure drug Ogivri that Biocon co-developed with its US-based partner Mylan, said the Indian biotech major on Wednesday.
"The EC has granted marketing authorisation for our cancer cure drug Ogivri, developed jointly with our partner Mylan," said the city-based firm in a statement here.
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) had earlier recommended approval of the drug as a biosimilar Trastuzumab to Roche's Herceptin on October 18.
The drug can be prescribed as monotherapy or in combination with other medicines depending upon the diagnosis under professional supervision.
2 hours ago
Medicare fraud plot nets doctor $5.4 million in conviction
2 hours ago
Accused of plotting murders against his ex-wife and her lover, a Boston man was imprisoned for the crime.
2 hours ago
India should be included to the list of "countries of particular concern," according to USCIRF.
2 hours ago
International students participating in university protests in the United States should be deported, according to Nikki Haley
2 hours ago
Eric Swalwell, a US congressman, claims that the Sikh community is the target of hate crimes.
2 hours ago
Biden claims xenophobia is a major economic obstacle for India and China.
4 hours ago
'Panchayat’ all set to return for its third season on May 28
4 hours ago
Sofia Vergara reveals why she can't be too picky about men
4 hours ago
Constituency Watch: The great family divide splits Baramati as 'Bhabhi-Nanad’ battle for uncle-nephew supremacy
4 hours ago
Kalpana celebrates 5th rescue anniversary at Mathura elephant hospital
4 hours ago
One killed, many injured as bus carrying Tripura bank job aspirants overturns in Assam
4 hours ago
Odisha Assembly elections: BJD declares last list of candidates
4 hours ago
TN quarry blast: Management announces Rs 12L compensation for victims' families